EP2480408A1 - Structures composites de fibres et de mousse, et procédés de fabrication - Google Patents
Structures composites de fibres et de mousse, et procédés de fabricationInfo
- Publication number
- EP2480408A1 EP2480408A1 EP10819437A EP10819437A EP2480408A1 EP 2480408 A1 EP2480408 A1 EP 2480408A1 EP 10819437 A EP10819437 A EP 10819437A EP 10819437 A EP10819437 A EP 10819437A EP 2480408 A1 EP2480408 A1 EP 2480408A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- foam
- fiber composite
- composite material
- material according
- fibers
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 238
- 239000002131 composite material Substances 0.000 title claims abstract description 118
- 239000006260 foam Substances 0.000 title claims abstract description 117
- 238000000034 method Methods 0.000 title claims description 26
- 238000004519 manufacturing process Methods 0.000 title description 15
- 239000002861 polymer material Substances 0.000 claims abstract description 8
- 229920000642 polymer Polymers 0.000 claims description 38
- 206010052428 Wound Diseases 0.000 claims description 31
- 208000027418 Wounds and injury Diseases 0.000 claims description 31
- 239000002243 precursor Substances 0.000 claims description 29
- 239000000654 additive Substances 0.000 claims description 23
- 239000007864 aqueous solution Substances 0.000 claims description 18
- 239000000839 emulsion Substances 0.000 claims description 18
- -1 sliver Substances 0.000 claims description 16
- 239000004816 latex Substances 0.000 claims description 15
- 229920000126 latex Polymers 0.000 claims description 15
- 239000005056 polyisocyanate Substances 0.000 claims description 13
- 229920001228 polyisocyanate Polymers 0.000 claims description 13
- 239000000376 reactant Substances 0.000 claims description 12
- 238000006243 chemical reaction Methods 0.000 claims description 11
- UPMLOUAZCHDJJD-UHFFFAOYSA-N 4,4'-Diphenylmethane Diisocyanate Chemical compound C1=CC(N=C=O)=CC=C1CC1=CC=C(N=C=O)C=C1 UPMLOUAZCHDJJD-UHFFFAOYSA-N 0.000 claims description 10
- 230000000996 additive effect Effects 0.000 claims description 10
- 238000009826 distribution Methods 0.000 claims description 10
- 229920001296 polysiloxane Polymers 0.000 claims description 7
- 239000004599 antimicrobial Substances 0.000 claims description 6
- 239000002537 cosmetic Substances 0.000 claims description 6
- 239000008406 cosmetic ingredient Substances 0.000 claims description 6
- 239000004745 nonwoven fabric Substances 0.000 claims description 6
- 230000035515 penetration Effects 0.000 claims description 6
- 229920002635 polyurethane Polymers 0.000 claims description 6
- 239000004814 polyurethane Substances 0.000 claims description 6
- DVKJHBMWWAPEIU-UHFFFAOYSA-N toluene 2,4-diisocyanate Chemical compound CC1=CC=C(N=C=O)C=C1N=C=O DVKJHBMWWAPEIU-UHFFFAOYSA-N 0.000 claims description 6
- 238000009581 negative-pressure wound therapy Methods 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- 125000003118 aryl group Chemical group 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- 239000003086 colorant Substances 0.000 claims description 4
- 239000002245 particle Substances 0.000 claims description 4
- 239000011782 vitamin Substances 0.000 claims description 4
- 229930003231 vitamin Natural products 0.000 claims description 4
- 229940088594 vitamin Drugs 0.000 claims description 4
- 235000013343 vitamin Nutrition 0.000 claims description 4
- 230000009471 action Effects 0.000 claims description 3
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000000844 anti-bacterial effect Effects 0.000 claims description 3
- 229940088710 antibiotic agent Drugs 0.000 claims description 3
- 239000003899 bactericide agent Substances 0.000 claims description 3
- 229960000074 biopharmaceutical Drugs 0.000 claims description 3
- 230000023555 blood coagulation Effects 0.000 claims description 3
- 239000000645 desinfectant Substances 0.000 claims description 3
- 239000003599 detergent Substances 0.000 claims description 3
- 239000003814 drug Substances 0.000 claims description 3
- 239000003974 emollient agent Substances 0.000 claims description 3
- 239000002657 fibrous material Substances 0.000 claims description 3
- 239000003063 flame retardant Substances 0.000 claims description 3
- 239000000314 lubricant Substances 0.000 claims description 3
- 239000002304 perfume Substances 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- 229920000247 superabsorbent polymer Polymers 0.000 claims description 3
- 239000004583 superabsorbent polymers (SAPs) Substances 0.000 claims description 3
- 239000001993 wax Substances 0.000 claims description 3
- 239000002759 woven fabric Substances 0.000 claims description 3
- 229920000049 Carbon (fiber) Polymers 0.000 claims description 2
- 239000004917 carbon fiber Substances 0.000 claims description 2
- 239000003365 glass fiber Substances 0.000 claims description 2
- 229920001477 hydrophilic polymer Polymers 0.000 claims description 2
- 230000005660 hydrophilic surface Effects 0.000 claims description 2
- 239000002557 mineral fiber Substances 0.000 claims description 2
- 229920000098 polyolefin Polymers 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 229920001730 Moisture cure polyurethane Polymers 0.000 claims 1
- 230000000845 anti-microbial effect Effects 0.000 claims 1
- 238000012377 drug delivery Methods 0.000 claims 1
- 230000002439 hemostatic effect Effects 0.000 claims 1
- 229920001600 hydrophobic polymer Polymers 0.000 claims 1
- 239000012948 isocyanate Substances 0.000 claims 1
- 150000002513 isocyanates Chemical class 0.000 claims 1
- 239000002184 metal Substances 0.000 claims 1
- 229920005573 silicon-containing polymer Polymers 0.000 claims 1
- 239000006261 foam material Substances 0.000 description 19
- 239000011159 matrix material Substances 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 239000000463 material Substances 0.000 description 16
- 229920005830 Polyurethane Foam Polymers 0.000 description 9
- 229920005862 polyol Polymers 0.000 description 9
- 150000003077 polyols Chemical class 0.000 description 9
- 239000011496 polyurethane foam Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 230000006872 improvement Effects 0.000 description 6
- 230000000704 physical effect Effects 0.000 description 6
- 239000004604 Blowing Agent Substances 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000007788 liquid Substances 0.000 description 4
- 238000002156 mixing Methods 0.000 description 4
- 229920001610 polycaprolactone Polymers 0.000 description 4
- 230000000379 polymerizing effect Effects 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 230000008901 benefit Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 229920001577 copolymer Polymers 0.000 description 3
- 210000000416 exudates and transudate Anatomy 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 229920000747 poly(lactic acid) Polymers 0.000 description 3
- 239000004632 polycaprolactone Substances 0.000 description 3
- 229920000728 polyester Polymers 0.000 description 3
- 239000004800 polyvinyl chloride Substances 0.000 description 3
- 229920000915 polyvinyl chloride Polymers 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 239000004971 Cross linker Substances 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 229920002323 Silicone foam Polymers 0.000 description 2
- 239000002250 absorbent Substances 0.000 description 2
- 230000002745 absorbent Effects 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 238000007664 blowing Methods 0.000 description 2
- WERYXYBDKMZEQL-UHFFFAOYSA-N butane-1,4-diol Chemical compound OCCCCO WERYXYBDKMZEQL-UHFFFAOYSA-N 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000013270 controlled release Methods 0.000 description 2
- 230000000249 desinfective effect Effects 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000004744 fabric Substances 0.000 description 2
- 229920001821 foam rubber Polymers 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000035876 healing Effects 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 238000002803 maceration Methods 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000570 polyether Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- YPFDHNVEDLHUCE-UHFFFAOYSA-N propane-1,3-diol Chemical compound OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 2
- 230000002787 reinforcement Effects 0.000 description 2
- GHMLBKRAJCXXBS-UHFFFAOYSA-N resorcinol Chemical compound OC1=CC=CC(O)=C1 GHMLBKRAJCXXBS-UHFFFAOYSA-N 0.000 description 2
- 239000013514 silicone foam Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- PZWQOGNTADJZGH-SNAWJCMRSA-N (2e)-2-methylpenta-2,4-dienoic acid Chemical compound OC(=O)C(/C)=C/C=C PZWQOGNTADJZGH-SNAWJCMRSA-N 0.000 description 1
- 229940083957 1,2-butanediol Drugs 0.000 description 1
- ZTNJGMFHJYGMDR-UHFFFAOYSA-N 1,2-diisocyanatoethane Chemical compound O=C=NCCN=C=O ZTNJGMFHJYGMDR-UHFFFAOYSA-N 0.000 description 1
- VGHSXKTVMPXHNG-UHFFFAOYSA-N 1,3-diisocyanatobenzene Chemical compound O=C=NC1=CC=CC(N=C=O)=C1 VGHSXKTVMPXHNG-UHFFFAOYSA-N 0.000 description 1
- IKYNWXNXXHWHLL-UHFFFAOYSA-N 1,3-diisocyanatopropane Chemical compound O=C=NCCCN=C=O IKYNWXNXXHWHLL-UHFFFAOYSA-N 0.000 description 1
- SBJCUZQNHOLYMD-UHFFFAOYSA-N 1,5-Naphthalene diisocyanate Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1N=C=O SBJCUZQNHOLYMD-UHFFFAOYSA-N 0.000 description 1
- 229940008841 1,6-hexamethylene diisocyanate Drugs 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 239000005057 Hexamethylene diisocyanate Substances 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 229920002302 Nylon 6,6 Polymers 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002732 Polyanhydride Polymers 0.000 description 1
- 239000005062 Polybutadiene Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004734 Polyphenylene sulfide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 229920001328 Polyvinylidene chloride Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 125000005396 acrylic acid ester group Chemical group 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229920006397 acrylic thermoplastic Polymers 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 229920003235 aromatic polyamide Polymers 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- DQXBYHZEEUGOBF-UHFFFAOYSA-N but-3-enoic acid;ethene Chemical compound C=C.OC(=O)CC=C DQXBYHZEEUGOBF-UHFFFAOYSA-N 0.000 description 1
- BMRWNKZVCUKKSR-UHFFFAOYSA-N butane-1,2-diol Chemical compound CCC(O)CO BMRWNKZVCUKKSR-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 238000005266 casting Methods 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- QEQJEMLMMYBHHM-SOMOIXMJSA-J dibismuth;potassium;sodium;(2r,3r)-2,3-dihydroxybutanedioate Chemical compound [Na+].[K+].[Bi+3].[Bi+3].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O.[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O QEQJEMLMMYBHHM-SOMOIXMJSA-J 0.000 description 1
- KORSJDCBLAPZEQ-UHFFFAOYSA-N dicyclohexylmethane-4,4'-diisocyanate Chemical compound C1CC(N=C=O)CCC1CC1CCC(N=C=O)CC1 KORSJDCBLAPZEQ-UHFFFAOYSA-N 0.000 description 1
- 125000005442 diisocyanate group Chemical group 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000004049 embossing Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- HGVPOWOAHALJHA-UHFFFAOYSA-N ethene;methyl prop-2-enoate Chemical compound C=C.COC(=O)C=C HGVPOWOAHALJHA-UHFFFAOYSA-N 0.000 description 1
- QHZOMAXECYYXGP-UHFFFAOYSA-N ethene;prop-2-enoic acid Chemical compound C=C.OC(=O)C=C QHZOMAXECYYXGP-UHFFFAOYSA-N 0.000 description 1
- 239000005038 ethylene vinyl acetate Substances 0.000 description 1
- 229920006226 ethylene-acrylic acid Polymers 0.000 description 1
- 229920006225 ethylene-methyl acrylate Polymers 0.000 description 1
- 239000005043 ethylene-methyl acrylate Substances 0.000 description 1
- 239000003733 fiber-reinforced composite Substances 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- RRAMGCGOFNQTLD-UHFFFAOYSA-N hexamethylene diisocyanate Chemical compound O=C=NCCCCCCN=C=O RRAMGCGOFNQTLD-UHFFFAOYSA-N 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- IQPQWNKOIGAROB-UHFFFAOYSA-N isocyanate group Chemical group [N-]=C=O IQPQWNKOIGAROB-UHFFFAOYSA-N 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000012457 nonaqueous media Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- 239000013500 performance material Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001084 poly(chloroprene) Polymers 0.000 description 1
- 229920001200 poly(ethylene-vinyl acetate) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920002857 polybutadiene Polymers 0.000 description 1
- 229920001707 polybutylene terephthalate Polymers 0.000 description 1
- 229920005906 polyester polyol Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 229920000069 polyphenylene sulfide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- AOHJOMMDDJHIJH-UHFFFAOYSA-N propylenediamine Chemical compound CC(N)CN AOHJOMMDDJHIJH-UHFFFAOYSA-N 0.000 description 1
- 238000004080 punching Methods 0.000 description 1
- 239000002964 rayon Substances 0.000 description 1
- 239000004627 regenerated cellulose Substances 0.000 description 1
- 239000012779 reinforcing material Substances 0.000 description 1
- 238000011012 sanitization Methods 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 230000037380 skin damage Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- ISXSCDLOGDJUNJ-UHFFFAOYSA-N tert-butyl prop-2-enoate Chemical compound CC(C)(C)OC(=O)C=C ISXSCDLOGDJUNJ-UHFFFAOYSA-N 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 229920001169 thermoplastic Polymers 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000004416 thermosoftening plastic Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- QXJQHYBHAIHNGG-UHFFFAOYSA-N trimethylolethane Chemical compound OCC(C)(CO)CO QXJQHYBHAIHNGG-UHFFFAOYSA-N 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000003039 volatile agent Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
- B32B5/24—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer
- B32B5/26—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer another layer next to it also being fibrous or filamentary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/01—Non-adhesive bandages or dressings
- A61F13/01008—Non-adhesive bandages or dressings characterised by the material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/425—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
- B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
- B29C44/00—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles
- B29C44/02—Shaping by internal pressure generated in the material, e.g. swelling or foaming ; Producing porous or cellular expanded plastics articles for articles of definite length, i.e. discrete articles
- B29C44/12—Incorporating or moulding on preformed parts, e.g. inserts or reinforcements
- B29C44/1209—Incorporating or moulding on preformed parts, e.g. inserts or reinforcements by impregnating a preformed part, e.g. a porous lining
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
- C08J9/0085—Use of fibrous compounding ingredients
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/04—Processes in which the treating agent is applied in the form of a foam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2250/00—Layers arrangement
- B32B2250/20—All layers being fibrous or filamentary
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
- B32B2260/02—Composition of the impregnated, bonded or embedded layer
- B32B2260/021—Fibrous or filamentary layer
- B32B2260/023—Two or more layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2260/00—Layered product comprising an impregnated, embedded, or bonded layer wherein the layer comprises an impregnation, embedding, or binder material
- B32B2260/04—Impregnation, embedding, or binder material
- B32B2260/046—Synthetic resin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/02—Organic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/02—Organic
- B32B2266/0207—Materials belonging to B32B25/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/02—Organic
- B32B2266/0214—Materials belonging to B32B27/00
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/02—Organic
- B32B2266/0214—Materials belonging to B32B27/00
- B32B2266/0221—Vinyl resin
- B32B2266/0235—Vinyl halide, e.g. PVC, PVDC, PVF, PVDF
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/02—Organic
- B32B2266/0214—Materials belonging to B32B27/00
- B32B2266/0278—Polyurethane
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/06—Open cell foam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2266/00—Composition of foam
- B32B2266/08—Closed cell foam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2307/00—Properties of the layers or laminate
- B32B2307/70—Other properties
- B32B2307/728—Hydrophilic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2555/00—Personal care
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2556/00—Patches, e.g. medical patches, repair patches
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2375/00—Characterised by the use of polyureas or polyurethanes; Derivatives of such polymers
- C08J2375/04—Polyurethanes
Definitions
- the invention relates generally to reinforced foam structures and, more specifically, to fiber-reinforced composite materials having increased durability and utility in fields such as personal care and medical care, particularly in the area of wound care.
- foam materials include, but are not limited to, polyurethane foam, polyvinyl chloride foam, polyimide foam, silicone foam, or latex foam.
- a different approach has been to take an existing matrix structure (e.g., a network of fibers) and embed shreds of previously formed foam material throughout the structure.
- the purpose of this approach is to make use of the strength properties of the matrix structure, but impart it with properties (e.g., hydrophilicity) of the foam material.
- the foam material has little or no structural integrity of its own.
- An aspect of the present invention provides a foam-fiber composite material comprising a monolithic foam structure comprising a polymer material and a fiber web comprising a plurality of fibers disposed substantially throughout the foam structure.
- Another aspect of the present invention provides a method of forming a foam- fiber composite material.
- the method comprises providing a web of fibers having a loft and a basis mass and providing a polymer foam precursor comprising a plurality of reactants.
- the method further comprises dispensing the polymer foam precursor onto the web of fibers and forcing penetration of the polymer foam precursor into and through the web of fibers.
- the method still further comprises allowing the polymer foam precursor reactants to react to form a monolithic foam structure having the plurality of fibers disposed throughout.
- the present invention provides composite materials comprising a continuous monolithic foam material throughout which is disposed a network or web of fibers.
- the fiber network may be disposed so as to provide reinforcement to the foam structure substantially through its entire extent.
- the distribution of the fibers within the foam structure may be homogeneous or heterogeneous.
- the fiber distribution may be systematically varied throughout the foam structure.
- different regions within the foam structure may have different fiber distributions, each of which may be homogeneous or heterogeneous. In the alternative or in addition, the fibers within these regions may have different fiber characteristics.
- the foam-fiber composite materials of the invention may be produced using a highly efficient, continuous production line.
- the process involves mixing the polymer foam reactants and immediately depositing the mixture onto a continuous web of fibers.
- the reactant mixture is forced into and through the fiber web. This may be accomplished using a nip roll or other doctoring tool, passage through which produces a sheet having a uniform thickness.
- the combined mixture/fiber web swells to form the final thickness of the composite material.
- the foam-fiber composites of the invention typically exhibit improved tensile strength and tear strength. They may also be structured to provide porosity or capillarity gradients through the material by the establishment of multiple cross-sectional regions having different fiber characteristics or distributions.
- a significant aspect of the invention is that the continuous manufacturing process used to produce the foam-fiber composite materials of the invention allows for mass- manufacturing in an inexpensive and efficient manner. It will be understood by those of ordinary skill in the art that this process may be used to manufacture composite materials using a wide variety of foam materials and fiber webs/fabrics. However, the foam-fiber composite materials may be either hydrophobic or hydrophilic.
- the foam-fiber composite material disclosed herein may be used in many applications, including long-term wound care, negative pressure wound therapy, cosmetics, and various cleaning applications.
- the composite material comprises a highly absorbent foam with hydrophilic properties and that is structurally enhanced by the fibers distributed throughout the foam.
- foam-fiber composite materials of the invention will now be described in more detail.
- any foam material may be used to form the foam- fiber composite materials of the invention including but not limited to polyurethane, silicone foam dispersions, latex foam dispersions and other polymeric systems.
- Polyurethane foams may be either open-cell or closed-cell and may be produced via reaction of any of a variety of polyisocyanates, crosslinking agents, surfactants, and polyols, and may use a catalyst and a blowing agent or pressurized gas. Blowing agents may include water or other auxiliary blowing agents commonly used in polyurethane foam production such as acetone, liquid carbon dioxide, ethyl acetate, hydrocarbons, fluorinated hydrocarbons.
- a hydrophilic, open cell polyurethane foam may be produced through a two step prepolymer-based method.
- the first step involves a reaction of polyisocyanate and a polyol to create a prepolymer with a stoichiometric excess of isocyanate groups.
- a crosslinker can also be added to create branching, thereby improving the physical characteristics of the hydrophilic foam.
- the second step involves a further reaction between the prepolymer and an aqueous solution.
- the aqueous solution may contain surfactants, colorants, antimicrobials, vitamins, controlled release agents and other like additives discussed below.
- the reaction between the prepolymer and the aqueous solution produces an open-celled, hydrophilic polyurethane foam, which may be used in a variety of applications, including, but not limited to, spot pressure relieving foams for respirator masks, foams for wound care applications, cosmetic applicator foams, and the like.
- Polyisocyanates useful in making prepolymers that can be used to produce foam structures for use in the invention include toluene diisocyanate (TDI) in the form of 2,4- and 2,6- isomers in the ratio of 80:20 or 65:35, diphenylmethane diisocyanate (MDI), polymeric diphenylmethane diisocyanate (PMDI), a mixture of various isomers of diphenylmethane diisocyanate, a mixture of TDI and MDI, isopherone diisocyanate (IPDI), dicyclohexylmethane- 4,4'-diisocyanate (Hi 2 MDI), 1 ,6-hexamethylene diisocyanate (HDI), polyaryl polymethylene polyisocyanate (PAPI), ethylene diisocyanate, cyclohexylene-l ,2-diisocyante, cyclohexylene- 1 ,4-di
- Polyols that may be used in this invention include polyether polyols, polyester polyols (for example, polycaprolactone), polyoxyalkylene polyols (for example, polyoxyethylene polyols), oxyethylene-oxypropylene block copolymer polyols, polyols with hydroxyl
- Crosslinkers that may be used in this invention include propylene glycol, 1 ,2- butanediol, 1,3-butanediol, 1 ,4-butanediol, trimethylene glycol, trimethylolpropane,
- trimethylolethane glycerol, pentaerythritol, sucrose, triethanolamine, triisopropanolamine, resorcinol, ethylene diamine, propylene diamine, catechol, and the like.
- Off-the-shelf prepolymers that can be used to produce polyurethane foams in various embodiment of the invention include such products as PrePol (Filtrona Porous
- the aqueous solution used to produce the foam structure of the invention may be water or an emulsion of water and surfactants.
- aqueous emulsions that may be used include, but are not limited to, polyvinyl alcohols, vinyl acetate, polyvinyl acetates, polyvinylidene chlorides, polyvinylchloride latex, silicone emulsions including SM 2138 (from Momentive Performance Materials), polychloroprene latex, acrylonitrile, SBR latex, NBR latex, carboxylated copolymer latex, acrylic latex, and other lattices, acrylic acid ester polymers or copolymers, or other polymeric systems.
- the amount of aqueous solution or latex or silicone emulsion as a percentage of the prepolymer may be upwards of 500% or even higher.
- the latex and silicone emulsions are particularly useful in yielding viscoelastic type foams that can be incorporated into fiber composite materials.
- a non-aqueous solution may also be used to produce the foam structure of the invention, and may be a mixture of polyoxyalkylene polyol, a surfactant, a blowing agent, and a catalyst.
- the aqueous or non-aqueous solutions may optionally include various additives, some of which are intended to be released from, others of which are intended to remain in, the foam-fiber composite material when the material is exposed to a certain environment and/or applied to a certain substrate (e.g., as a wound care dressing).
- the releasable additives may be or include volatile ingredients and/or bioactive additives including, but not limited to, antimicrobials, antibiotics, vitamins such as vitamin E, silver or silver derivatives, lubricants, biologicals, pharmaceuticals, bactericides, botanicals, cosmetic ingredients, perfumes, detergents, soaps, disinfectants, solid particles, emollients, volatiles, and other like additives.
- the releasable additives may comprise controlled-release mechanisms or structures that serve to control the timing or duration of release of the releasable additive for interaction with another material or surface.
- the unreleasable additives may be or include blood clotting agents such as chitosan, flame retardants, cosmetic ingredients, colorants, waxes, superabsorbent polymers, cellulosic polymers, solid particles, and other like additives.
- the releasable or unreleasable additives described above may be incorporated into the foam-fiber composite material by mixing with the prepolymer component of the foam instead of or in addition to the aqueous component.
- the relative amount of releasable or unreleasable additives that can be added will depend on the specific foam materials and the nature and desired use of the additive. Typically, however, the amount of the releasable or unreleasable additive will be in a range of 0.0001 percent to about 80 percent by weight of the dry foam material.
- any foam material may be used to form the composite materials of the invention.
- the foam material it is desirable that the foam material be biodegradable.
- the product may be biodegradable if both components (foam and fiber) are hydrolytically unstable, and therefore would undergo degradation under aqueous conditions.
- Exemplary biodegradable foams that may be used in the invention may be produced by making the prepolymer with any of various degradable polyesters (i.e., instead of polyethers) and aliphatic diisocyanates such as Desmodur® W (H 12 MDI) (instead of aromatic TDI, MDI).
- Open cell hydrophilic foams made in the above manner have several advantages, including superior water absorption and purity levels. This makes them valuable for stringent medical applications. Unreinforced foams of this type do, however, have several disadvantages: they tend to swell significantly when wet, have relatively poor tensile and tear strength when dry, and have even poorer tensile and tear strength when wet. They also have a relatively
- homogeneous, or isotropic, pore structure which means that they may not be configured to contain a gradient of porosity or capillarity, which would serve to move or pull liquid from one side of the foam construction to the other in a variable, but controlled, manner.
- the composite materials of the invention overcome the above-described disadvantages through the incorporation of fibers throughout the foam structure.
- the fiber network of the foam-fiber composite materials of the invention may be or comprise virtually any woven or non-woven fiber web.
- the fibers themselves may be comprised of synthetic or natural polymers or may be non-polymeric. If polymeric, the fibers may be any of a variety of fiber types including extruded fibers, monocomponent fibers, multicomponent fibers, melt-blown fibers, wet-spun fibers, dry-spun fibers, bonded fibers, natural fibers, and the like.
- the composition of the fibers may include any thermoplastic or thermoset polymeric material, including but not limited to, cellulose acetate, other acetates and esters of cellulose, virgin or regenerated cellulose, polyamides, such as nylons, including nylon 6 and nylon 66; polyolefins, such as polyethylene and polypropylene; polyesters including polyethylene terephthalate and polybutylene terephthalate; polyvinyl chloride; polymers of ethylene methacrylic acid, ethylene acrylic acid, ethylene vinyl acetate, or ethylene methyl acrylate; polystyrene; polysulfones; polyphenylene sulfide; polyacetals; acrylics and polymers comprising blocks of polyethylene glycol; as well as copolymers and derivatives of all of the foregoing.
- polyamides such as nylons, including nylon 6 and nylon 66
- polyolefins such as polyethylene and polypropylene
- polyesters including polyethylene terephthalate and polybut
- Biodegradable polymeric materials that may be used include polycaprolactone (PCL), polyglycolide (PGA), polylactide (PLA), polyaramides, natural fibers (e.g. cotton, wool), and the like.
- PCL polycaprolactone
- PGA polyglycolide
- PLA polylactide
- Paramides polyaramides
- natural fibers e.g. cotton, wool
- Non-organic fibers such as carbon fibers, glass fibers and mineral fibers may also be used.
- the fiber webs used in the invention may be provided in a variety of forms. For example, they may be provided in bulked or un-bulked form. Any or all of the fibers may be provided as bonded or unbonded webs of staple or continuous fibers (e.g., filaments or tows).
- the fiber web may be comprised in the form of a woven or non-woven fabric. In a non-woven fabric, the fibers may, in some embodiments, be thermally, chemically, or mechanically (e.g., by needle punching, hydro entanglement, embossing, and the like) bonded to one another at spaced apart points of contact.
- the fibers may be formed and collected using any of the methods disclosed in U.S. Pat. Nos. 5,607,766; 6, 103, 181 ; and 7,290,668 and U.S. Pat. App. No.
- the fiber portion of foam-fiber composite materials are provided in the form of non-woven sheets of polymeric staple fibers.
- Such non-woven materials have proven advantageous in the manufacturing process and in yielding improved physical properties of the final foam-fiber composite.
- the non-woven sheets may be made by one of a number of different methodologies and can have high loft, or thickness, or can be "flat" ( i.e., have a very low loft).
- non-woven textiles When formed of either hydrophilic fibers or fibers featuring a hydrophilic surface finish, non-woven textiles have absorbency properties that make them particularly suitable for certain medical applications. (Non-woven polyester rayon constructions, for example, are widely used in wound care applications as bandage media (e.g., gauze)).
- the foam-fiber composite materials of the invention may be formed by a continuous manufacturing process in which a continuous fiber web provides a matrix into which an as-yet unreacted or only partially reacted polymer foam precursor is introduced. When the polymer reacts (or as it continues to react) to form the cells of the foam structure, it expands throughout the fiber matrix. As has been discussed, a goal of the method is to produce a composite in which the fiber matrix extends substantially throughout the foam material. It has been found, however, that this may be accomplished only through the use of certain criteria to match the amount and nature of the foam material to characteristics of the fiber web such as its loft, thickness, density and porosity.
- the roll gap of the nip roller and the flow rate of the polymer foam precursor should be set so that the resulting thickness of the foam component is approximately equal to the initial thickness of the fiber web prior to indoctrination of the precursor into the web. This tends to assure that the fibers of the web are completely distributed throughout the foamed material in a rapid manner. In effect, the foam and fiber matrix is created upon pouring and then immediately passed through a nip roller gap. Composite materials produced in this manner exhibited improved tensile and tear strength compared to native (unreinforced) foam.
- the manufacturing process involves preparing a polymer foam precursor (e.g., by mixing a prepolymer with an aqueous solution) in a mix head. If any releasable or unreleasable additives are to be included they may be added to one or both of the constituents (i.e., the prepolymer or the aqueous solution) prior to combining the materials in the mix head or may be added separately into the mixture.
- the polymer foam precursor is then deposited onto a fiber web via a mix head. As discussed above, the fiber web may be in the form of a woven or non-woven fabric.
- the polymer foam precursor is continuously deposited on a continuous fiber web and then passed through a doctoring device such as a nip roller to force the polymer foam precursor to penetrate and saturate the fiber matrix.
- a doctoring device such as a nip roller to force the polymer foam precursor to penetrate and saturate the fiber matrix.
- the indoctrination of the polymer foam precursor is accomplished prior to any significant expansion due to a blowing reaction.
- the blowing reaction itself may be initiated through the mixing of the materials making up the polymer foam precursor (as is the case in the example above for the hydrophilic polyurethane foam) or through subsequent initiation of a blowing agent within the polymer foam precursor.
- Using a nip roller in this manner to force the penetration and saturation of the fiber matrix, and doing so at this stage of the reaction, allows for rapid production of a foam structure with fibers distributed throughout the foam (or if desired through a portion of the foam), and a continuous foam-fiber composite material having a uniform thickness that may later be cut into a desired length or shape.
- the gap of the nip roller may be adjusted to control the thickness of the foam-fiber composite. Different thicknesses of the foam-fiber composite may also be obtained by using fiber webs with different thicknesses and adjusting the nip roller gap to correspond to these thicknesses.
- the manufacturing process comprises dispensing the polymeric foam precursor (e.g., a hydrophilic polymerizing mixture of
- the release liners, fiber matrix, and hydrophilic polymerizing mixture are then fed through a nip roller to force penetration of the hydrophilic polymerizing mixture into the fiber matrix.
- This "sandwich" approach improves the quality of the composite material and provides for easy removal of the composite at the end of the casting line.
- the top and bottom release liners are removed at the end of the production line when the foam-fiber composite material becomes tack free.
- the foam- fiber composite material may then be dried in an oven or similar device.
- the fiber matrix may have a basis mass in a range of 1-500 gsm (g/m " ) and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 0.5 to 50 mm. In these embodiments, average fiber diameter will typically be in a range of 5- 100 ⁇ . In some advantageous embodiments, the fiber matrix may have a basis mass in a range of 100-200 gsm and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 25 to 50 mm. In other advantageous embodiments, the fiber matrix may have a basis mass in a range of 10-125 gsm and, prior to combining with the polymer foam precursor, a loft, or caliper, in a range of about 0.5 to 6.0 mm.
- the fiber web or matrix may be made up of multiple fiber layers or webs arranged one on top of the other or in a side-by-side
- the resulting multi-layer web may be used as the fiber component during a single manufacturing process to obtain a single integrally formed foam-fiber composite material. If, however, the fiber layers have different properties (e.g., basis mass, loft, density, etc.), the resulting foam-fiber composite material will be formed with a plurality of cross-sectional regions of differing characteristics. Each of these regions may have a distribution of fibers that is different from the distribution of fibers in each other region. Some or all of these regions may have homogeneous fiber distributions and each region may have different physical
- the foam-fiber composite material may have multiple distinct fiber layers which are intentionally of different basis masses along the width of the foam-fiber web and therefore create intentionally different physical characteristics of the foam-fiber web along its width.
- one fiber web having a basis mass of 25 gsm may be placed along side or on top, or partially covering another fiber web having a basis mass of 75 gsm, either thermally bonded together or not bonded together, and then combined with the polymer foam precursor to obtain a gradient-type foam-fiber composite material.
- the portion of the foam-fiber composite material having the fiber web with a basis mass of 75 gsm will be more dense than the portion having a fiber web with a basis mass of 25 gsm, but the fibers will nevertheless be distributed throughout the entire foam component without breaking the cross- linked molecular network of the foam, thereby allowing the foam to be monolithic.
- the gradient nature of such a foam-fiber composite material is useful in the wound care setting because it allows for more rapid transfer of liquid exudates away from the wound via gradient capillary action.
- Other parameters that may be varied from web to web in a multi-web composite include but are not limited to variations in fiber type, fiber diameter, fiber material or structure, and web or fabric structure (e.g., woven versus non-woven, bonded versus unbonded, etc). Any of these variations may be tailored to provide the desired characteristics in different cross- sectional regions of the resulting foam-fiber composite material.
- the resultant foam-fiber composite material advantageously may have a thickness of approximately 1 - 50 mm for wound care or cosmetic applications.
- Thicker foam-fiber composite materials may be produced by using a fiber component with a higher loft and by applying additional polymer foam precursor, and setting the nip roller to have a larger roll gap.
- a range of 1 - 50 mm has been found to be advantageous in wound care applications.
- Foam-fiber composite materials having a thickness from 20 - 40 mm are particularly useful in negative pressure wound therapy applications because of their increased strength.
- Hydrophilic foam-fiber composite materials having the structure described above are well suited for wound care applications because they allow for rapid transfer of liquid exudates away from the wound via gradient capillarity. This promotes more rapid healing and reduces maceration of healthy skin surrounding the wound.
- One or more surfaces of the composite material may also be coated with silicone or glycerin coatings, which can reduce sticking to the wound and therefore reduce pain and damage during changing of wound dressings.
- releasable and/or unreleasable additives may be incoiporated into the foam structure, and the releasable additives may be later released when the foam-fiber composite material is exposed to a particular environment (e.g., immersion in a fluid) or applied to a surface (e.g., application to the skin as a bandage).
- a particular environment e.g., immersion in a fluid
- a surface e.g., application to the skin as a bandage
- foam-fiber composite materials according to embodiments of the invention have been produced and have demonstrated improved tensile strength, tear strength, and swelling properties over unreinforced foam materials.
- the composite materials produced have included structures with preordained gradient porosity or capillarity, and have been shown to be manufacturable in an inexpensive and efficient manner.
- Table 1 lists the physical characteristics of a hydrophilic polyurethane foam-fiber composite materials prepared in accordance with one exemplary embodiment of the invention.
- a hydrophilic prepolymer (specifically, PrePol)/aqueous solution mixture was poured onto a 2 mm thick non-woven fiber having a basis mass of 25 gsm.
- the thickness of the final composite was controlled by making adjustments to the gap height of the nip roller. In this Example, the nip roller gap height was set to about 2 mm.
- the fiber matrix (fiber component) of the resulting composite material was distributed throughout the entire foam component and was distributed substantially homogeneously throughout the foam.
- the foam-fiber composite material was then subjected to a drying process to remove excess water.
- a comparison was made with a 2.5 mm thick hydrophilic foam and the results are summarized in Table 1 .
- MD Machine Direction of the fiber
- TD Transverse Direction (i.e., Transverse to Machine Direction)
- a dry hydrophilic foam-fiber composite material according to a first exemplary embodiment of the invention showed a 73% increase in tensile strength in a direction transverse to the machine direction (i.e., the direction along which the materials are drawn as the composite material is produced) and a 905% increase in tear strength in the same transverse direction compared to a dry unreinforced hydrophilic foam of approximately the same thickness. Further, these significant improvements in tensile and tear strength were achieved while maintaining approximately the same elongation characteristics in the same transverse direction.
- the foam- fiber composite materials exhibit different tensile and elongation characteristics when tested across the web (transverse direction) than when tested along the web (machine direction). This is in contrast to the unreinforced foam specimen which does not show significant difference in machine direction and transverse direction results due to uniform cell structure of the foam. Dry foam- fiber composites tested in a transverse direction showed lower tensile and higher elongation values compared to similar samples tested in a machine direction. This, however, is a function of the particular fiber material used in this example and does not exemplify results for all other non-woven or woven structures, which may have comparable results for both the transverse and machine directions.
- the foam-fiber composite material of Example 1 shows a 382-485% increase in tear strength even when wet, compared to a dry unreinforced hydrophilic foam of similar thickness, and a 2543%- 3106% increase in tear strength even wet, compared to a wet unreinforced hydrophilic foam.
- the foam-fiber composite material according to Example 1 shows significant improvements in tensile strength and tear strength even when wet while maintaining adequate hydrophilic characteristics such that it may be advantageously used in wound dressing, medical, cosmetic and other applications where natural hydrophilic characteristics coupled with higher strength are required.
- resulting foam-fiber composite materials can be used as a cleaning pad with or without antimicrobial agents, alone or attached to a substrate, to apply water based, water emulsion based, and oil based treatments such as would be useful in sanitizing or disinfecting applications.
- Table 2 lists the physical characteristics of a hydrophilic foam-fiber composite mmaatteerriiaall pprreepploreedd iinn aaccccoorrddaannccee wwiitthh aannootthheerr eexxeemmppllaarryy eemmbbooddiimmeenntt ooff tthhee iinnvveennttiioonn..
- Example 2 shows data from Example 2 tested in the machine direction (MD). As shown in Table 2, the foam-fiber composite material according to Example 2 exhibits the same trends as seen in Example 1. The foam-fiber composite material showed a 568% increase in tensile strength and a 463% increase in tear strength (machine direction) compared to the dry unreinforced hydrophilic foam of approximately the same thickness. Thus, the physical properties that are critical for wound care applications (tensile and tear strength) were far superior to those for the unreinforced hydrophilic foam of approximately the same thickness. EXAMPLES 3-7
- Table 3 lists the physical properties of hydrophilic foam-fiber composite materials prepared in accordance with other exemplary embodiments of the invention.
- multiple fiber layers were bonded together and a hydrophilic polymer foam precursor was poured onto the bonded fiber, and run through a nip roller to achieve a consistent thickness.
- Each example has an approximate average thickness of 5 mm, and is compared to an
- unreinforced hydrophilic foam material of approximately 5 mm.
- Each fiber layer had a basis mass of either 25 gsm or 75 gsm and a loft ranging from 1-15 mm.
- the plurality of fiber webs were bonded together to yield a single fiber web/matrix and, at the same time, produce the desired loft before the polymerizing mixture of prepolymer and aqueous solution was dispensed onto it.
- a predetermined variable distribution of fibers throughout the foam was achieved by bonding together fiber layers having a different basis mass (e.g., 25 gsm and 75 gsm).
- Table 3 Physical properties of dry hydrophilic foam-fiber composite materials prepared usin bonded multila er fiber webs.
- Examples 3-7 are significantly higher than those of the unreinforced hydrophilic foam. Further, foam-fiber composite materials having fiber webs with a basis mass of 75 gsm show greater tensile and tear strength properties than those having fiber webs with a basis mass of 25 gsm.
- Table 4 lists the physical properties of a hydrophilic foam-fiber composite material according to yet another exemplary embodiment of the invention.
- a hydrophilic polyurethane foam-fiber composite material was prepared as above but with a thicker fiber matrix such as may be used for negative pressure wound therapy (NPWT) applications.
- the foam-fiber composite material in this example was prepared by dispensing a mixture of prepolymer and aqueous solution onto a rolled fiber matrix of approximately 50 mm thickness, and then fed through a nip roller having a roll gap of approximately 25 mm.
- the foam-fiber composite material was sandwiched between two release liners as described above. The two release liners were removed at the end of the production line and the foam-fiber composite material was dried in an oven to remove excess water.
- the foam-fiber composite material according to this exemplary embodiment of the invention shows much greater tear strength for the dry foam-fiber composite material than the unreinforced dry hydrophilic foam in both the transverse and machine directions of the fiber web while maintaining similar absorbent characteristics.
- the tensile and tear strength values of wet fiber reinforced specimens were increased by 78% and 493% respectively in the transverse direction compared to wet unreinforced foam materials.
- the improvements in machine direction were 109% and 622% respectively.
- a thicker foam-fiber composite material is useful in negative pressure wound therapy applications because it is able to withstand forces inherent in such applications where a controlled sub-atmospheric or negative pressure is applied to the wound bed with a tube threaded through the dressing via a vacuum source to promote the moist wound healing process of acute or chronic wounds.
- Examples 9A-E are foam-fiber composite materials according to additional embodiments of the invention. These embodiments comprise latex and other emulsions to produce the foam component of the foam-fiber composite materials. These emulsions and their loading level in the aqueous solution are shown in the Table 5. These aqueous emulsion solutions were mixed with PrePol prepolymer and MDI based prepolymers and poured onto thin fiber webs to obtain foam-fiber composite materials.
- the non-volatile solid content of the above emulsions may be in the range of 20-70 wt %.
- Products made from the foam-fiber composites described above have utility in a number of applications, including, but not limited to, dressings for wound care, cosmetic, household cleaning/disinfecting applications.
- One advantage of the medical grade foam-fiber composite materials is the rapid transfer of exudate fluids away from the wound to facilitate healing of wounds, especially wound tunnel and deep wound cavity treatments and chronic wounds that may be a byproduct of diabetes and burns.
- the foam-fiber composite materials described herein have further utility in that they are substantially clean as a result of their resistance to shedding debris, allow for dressing changes without the pain of sticking to the wound surface, and reduce maceration of good skin in the area surrounding the wound.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Textile Engineering (AREA)
- Dispersion Chemistry (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Nonwoven Fabrics (AREA)
- Materials For Medical Uses (AREA)
Abstract
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24507609P | 2009-09-23 | 2009-09-23 | |
US12/887,943 US20110070423A1 (en) | 2009-09-23 | 2010-09-22 | Foam and Fiber Composite Structures and Methods of Manufacture |
PCT/US2010/049951 WO2011038084A1 (fr) | 2009-09-23 | 2010-09-23 | Structures composites de fibres et de mousse, et procédés de fabrication |
Publications (2)
Publication Number | Publication Date |
---|---|
EP2480408A1 true EP2480408A1 (fr) | 2012-08-01 |
EP2480408A4 EP2480408A4 (fr) | 2014-01-22 |
Family
ID=43796198
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP10819437.4A Withdrawn EP2480408A4 (fr) | 2009-09-23 | 2010-09-23 | Structures composites de fibres et de mousse, et procédés de fabrication |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP2480408A4 (fr) |
WO (1) | WO2011038084A1 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4417243A1 (fr) | 2023-02-15 | 2024-08-21 | Heraeus Medical GmbH | Implant pour libération prolongée de médicament |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL226081B1 (pl) * | 2012-02-16 | 2017-06-30 | Politechnika Łódzka | Material medyczny i sposob jego wytwarzania oraz zastosowanie materialu medycznego |
WO2014142959A1 (fr) * | 2013-03-15 | 2014-09-18 | Tempur-Pedic Management, Llc | Composite de mousse et ses procédés de fabrication |
TWI594742B (zh) * | 2013-07-05 | 2017-08-11 | Wound covering and method of making the same | |
US10729600B2 (en) | 2015-06-30 | 2020-08-04 | The Procter & Gamble Company | Absorbent structure |
WO2017079601A1 (fr) * | 2015-11-04 | 2017-05-11 | The Procter & Gamble Company | Structure absorbante |
CN108348387B (zh) | 2015-11-04 | 2021-05-28 | 宝洁公司 | 吸收结构 |
GB201712162D0 (en) * | 2017-07-28 | 2017-09-13 | Smith & Nephew | Absorbent article and method of manufacture |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2115237A1 (de) * | 1971-03-30 | 1972-10-05 | Johann Otto Zentgraf KG, 8019 Steinhöring | Bürstenschwamm oder Schwammbürstentücher mit stark gewinkelten, gewellten Bürstenfasern, im Schaumstoff eingeschlossen |
EP1600096A2 (fr) * | 2004-05-26 | 2005-11-30 | The Clorox Company | Substrat comportant une mousse |
US20070079462A1 (en) * | 2005-10-06 | 2007-04-12 | Haskett Thomas E | Scouring web and method of making |
DE102006005984A1 (de) * | 2006-02-08 | 2007-08-09 | Carl Freudenberg Kg | Reinigungstuch |
WO2007101881A2 (fr) * | 2006-03-09 | 2007-09-13 | Basf Se | Composite en couches composé d'une mousse de résine de mélamine à cellules ouvertes et d'un non-tissé ou d'un tissu de fibres de mélamine |
WO2009007926A2 (fr) * | 2007-07-12 | 2009-01-15 | Kimberly-Clark Worldwide, Inc. | Éponge à main gonflante avec indicateur de changement de couleur |
WO2009007924A2 (fr) * | 2007-07-12 | 2009-01-15 | Kimberly-Clark Worldwide, Inc. | Éponge à main gonflante avec indicateur de changement de couleur |
WO2010118320A2 (fr) * | 2009-04-10 | 2010-10-14 | 3M Innovative Properties Company | Éponge de nettoyage |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1243545A (fr) * | 1958-10-06 | 1960-10-14 | Owens Corning Fiberglass Corp | Produit fibro-cellulaire et son procédé de fabrication |
US3962388A (en) * | 1973-01-02 | 1976-06-08 | Sun Research And Development Co. | Method of producing a foam fibrillated web |
US4450833A (en) * | 1981-12-02 | 1984-05-29 | Brooks William R | Method of dimensioning a polyurethane foam bandage |
US5338766A (en) * | 1993-03-26 | 1994-08-16 | The Procter & Gamble Company | Superabsorbent polymer foam |
US6224961B1 (en) * | 1997-08-01 | 2001-05-01 | The Procter & Gamble Company | Absorbent macrostructure made from mixtures of different hydrogel-forming absorbent polymers for improved fluid handling capability |
US20060246272A1 (en) * | 2005-04-29 | 2006-11-02 | Zhang Xiaomin X | Thermoplastic foam composite |
-
2010
- 2010-09-23 EP EP10819437.4A patent/EP2480408A4/fr not_active Withdrawn
- 2010-09-23 WO PCT/US2010/049951 patent/WO2011038084A1/fr active Application Filing
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2115237A1 (de) * | 1971-03-30 | 1972-10-05 | Johann Otto Zentgraf KG, 8019 Steinhöring | Bürstenschwamm oder Schwammbürstentücher mit stark gewinkelten, gewellten Bürstenfasern, im Schaumstoff eingeschlossen |
EP1600096A2 (fr) * | 2004-05-26 | 2005-11-30 | The Clorox Company | Substrat comportant une mousse |
US20070079462A1 (en) * | 2005-10-06 | 2007-04-12 | Haskett Thomas E | Scouring web and method of making |
DE102006005984A1 (de) * | 2006-02-08 | 2007-08-09 | Carl Freudenberg Kg | Reinigungstuch |
WO2007101881A2 (fr) * | 2006-03-09 | 2007-09-13 | Basf Se | Composite en couches composé d'une mousse de résine de mélamine à cellules ouvertes et d'un non-tissé ou d'un tissu de fibres de mélamine |
WO2009007926A2 (fr) * | 2007-07-12 | 2009-01-15 | Kimberly-Clark Worldwide, Inc. | Éponge à main gonflante avec indicateur de changement de couleur |
WO2009007924A2 (fr) * | 2007-07-12 | 2009-01-15 | Kimberly-Clark Worldwide, Inc. | Éponge à main gonflante avec indicateur de changement de couleur |
WO2010118320A2 (fr) * | 2009-04-10 | 2010-10-14 | 3M Innovative Properties Company | Éponge de nettoyage |
Non-Patent Citations (1)
Title |
---|
See also references of WO2011038084A1 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4417243A1 (fr) | 2023-02-15 | 2024-08-21 | Heraeus Medical GmbH | Implant pour libération prolongée de médicament |
Also Published As
Publication number | Publication date |
---|---|
EP2480408A4 (fr) | 2014-01-22 |
WO2011038084A1 (fr) | 2011-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110070423A1 (en) | Foam and Fiber Composite Structures and Methods of Manufacture | |
EP2480408A1 (fr) | Structures composites de fibres et de mousse, et procédés de fabrication | |
US9000252B2 (en) | Wound dressing | |
KR101633521B1 (ko) | 다층 복합 재료, 이의 제조 및 이의 용도 | |
US10953127B2 (en) | Absorbent foam wound dressing materials | |
EP1923077B1 (fr) | Pansement multicouche absorbant avec une couche hydrophile en contact de plaies | |
CN108348361B (zh) | 吸收结构 | |
EP2039328B1 (fr) | Matériau de recouvrement d'une plaie | |
RU2565431C2 (ru) | Композитное многослойное гемостатическое устройство | |
JP5514816B2 (ja) | 創傷被覆材 | |
CN102596560B (zh) | 医疗制品及使用可混溶组合物进行制备的方法 | |
CN101563491B (zh) | 水刺非织造织物、工艺、产品和设备 | |
US20080014386A1 (en) | Cohesive articles with a foam layer | |
JP5934111B2 (ja) | 柔軟性のある高吸収性を有する材料 | |
WO2010026251A1 (fr) | Article pour le soin des plaies contenant une proportion de fibres naturelles modifiées ou de fibres synthétiques | |
FR2464076A1 (fr) | Materiau activable par l'eau pour preparer des appareils orthopediques de contention et procede de son utilisation | |
WO2006073757A2 (fr) | Mousse absorbante contenant des fibres | |
EP2593058A1 (fr) | Article pour le traitement de plaies par l'utilisation de microfibres contenant une pression négative | |
KR101202875B1 (ko) | 메쉬 필름을 포함하는 친수성 폴리우레탄 폼 드레싱재 및 그의 제조방법 | |
CA2892249C (fr) | Mats fibreux non tisses absorbants presentant une forte resistance mecanique | |
CN115023205A (zh) | 用于伤口敷料的双涂层 | |
EP3960025B1 (fr) | Corps stratifié de fibres et son procédé de production | |
GB2464970A (en) | Wound dressing comprising fibrous plugs | |
KR20180075812A (ko) | 항균성 폴리우레탄 폼 드레싱재 및 이의 제조방법 | |
CN1224372A (zh) | 吸收性制鞋材料 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20120229 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20140103 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: B32B 5/28 20060101ALI20131218BHEP Ipc: B32B 5/22 20060101AFI20131218BHEP |
|
RAP1 | Party data changed (applicant data changed or rights of an application transferred) |
Owner name: ESSENTRA POROUS TECHNOLOGIES CORP. |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160401 |